A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

Published:2014-12 Issue:12 Volume:6 Page:
ISSN:1756-994X
Container-title:Genome Medicine
language:en
Short-container-title:Genome Med

Author:

Haider Syed,Wang Jun,Nagano Ai,Desai Ami,Arumugam Prabhu,Dumartin Laurent,Fitzgibbon Jude,Hagemann Thorsten,Marshall John F,Kocher Hemant M,Crnogorac-Jurcevic Tatjana,Scarpa Aldo,Lemoine Nicholas R,Chelala Claude

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13073-014-0105-3.pdf

Reference50 articles.

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322/caac.20073.

2. Hidalgo M: Pancreatic cancer. N Engl J Med. 2010, 362: 1605-1617. 10.1056/NEJMra0901557.

3. Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, Routh ED, Caskey LS, Samuel JC, Der CJ, Thorne LB, Calvo BF, Kim HJ, Talamonti MS, Iacobuzio-Donahue CA, Hollingsworth MA, Perou CM, Yeh JJ: A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med. 2010, 7: e1000307-10.1371/journal.pmed.1000307.

4. Stathis A, Moore MJ: Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010, 7: 163-172. 10.1038/nrclinonc.2009.236.

5. Plentz RR, Manns MP, Greten TF: Molecular therapy of pancreatic cancer. Minerva Endocrinol. 2010, 35: 27-33.

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic subtyping of gastrointestinal malignancies;Trends in Cancer;2024-09

2. Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells;Oncology Letters;2024-07-05

3. Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction;Journal of Gastroenterology;2024-04-29

4. MicroRNA-130b Suppresses Malignant Behaviours and Inhibits the Activation of the PI3K/Akt Signaling Pathway by Targeting MET in Pancreatic Cancer;Biochemical Genetics;2024-04-12

5. Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer;British Journal of Cancer;2024-04-10